CCR1 as a target for multiple myeloma

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.9, 2011-09, pp. : 1037-1047

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CCR5 as Target for HIV-1 Gene Therapy

Current Gene Therapy, Vol. 8, Iss. 4, 2008-08 ,pp. : 264-272

Bentham Science Publishers

Access to resources Recommend Favorite

The kinase NIK as a therapeutic target in multiple myeloma

By Gardam Sandra Beyaert Rudi

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 207-218

Informa Healthcare

Access to resources Recommend Favorite

P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma (Supplementry Material)

Current Cancer Drug Targets, Vol. 9, Iss. 5, 2009-08 ,pp. : 617-625

Bentham Science Publishers

Access to resources Recommend Favorite

The mTOR Signaling Pathway is an Emerging Therapeutic Target in Multiple Myeloma

Current Pharmaceutical Design, Vol. 20, Iss. 1, 2014-01 ,pp. : 125-135

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple myeloma

By Samson Diana Singer Charles

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 365-370

Royal College Of Physicians

Access to resources Recommend Favorite